Doctor profile · Federal record
Dr. NAMRATA VIJAYVERGIA, M.D.
Medical Oncology Physician (CMS: HEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY) · PHILADELPHIA, PA
- NPI 1871741025
- Accepts Medicare
- MIPS 72.5 / 100 · 2023
- 19 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
333 COTTMAN AVE
PHILADELPHIA, PA 191112434
(215) 728-6900
fax (215) 214-3779 - Mailing address
-
2450 W HUNTING PARK AVE
PHILADELPHIA, PA 191291302
Credentials & registration
- NPI registered
- August 2008 — 18 yrs on file
- Profile last updated
- April 9, 2018
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Pennsylvania #MD443108
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871741025. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
377
Distinct HCPCS
4
Medicare allowed
$48,067
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 174 | 80 | $149 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 156 | 86 | $101 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 31 | 31 | $189 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 16 | 14 | $32 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 121. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$19,354
Transactions
24
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $10,500.00 | |
| Exelixis Inc. | 12 | $7,838.93 | |
| TerSera Therapeutics LLC | 1 | $520.00 | |
| Regeneron Pharmaceuticals, Inc. | 4 | $430.92 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $46.71 | |
| Astellas Pharma US Inc | 1 | $17.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
142
Patients
58
Total drug cost
$1,671
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Hcl | Generic | 33 | 24 | $326 |
| Prochlorperazine Maleate | Generic | 33 | 22 | $494 |
| Pantoprazole Sodium | Generic | 27 | 0 | $288 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 15 | 12 | $145 |
| Gabapentin | Generic | 12 | 0 | $126 |
| Lorazepam | Generic | 11 | 0 | $56 |
| Ondansetron Odt (Ondansetron) | Brand | 11 | 0 | $234 |